Evidence map›Paper›PMID 41073395›Full record

ArticleScientific reports2025

Twelve-year nationwide cohort study identifying risk factors for conversion from mild cognitive impairment to Alzheimer's disease.

Kyoungwon Baik, Minwoong Kang, Yu Jeong Park, Su Jin Chung, Kyungmi Oh, Seong-Beom Koh, Sung Hoon Kang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kyoungwon Baik *Department of Neurology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Minwoong Kang *Department of Biomedical Research Center, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Yu Jeong ParkDepartment of Neurology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul, 08308, Korea.
Su Jin ChungDepartment of Neurology, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
Kyungmi OhDepartment of Neurology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul, 08308, Korea. okyungmi@korea.ac.kr.
Seong-Beom KohDepartment of Neurology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul, 08308, Korea.
Sung Hoon KangDepartment of Neurology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul, 08308, Korea. shkang85@naver.com.

Funding

Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education grant number: 2022R1I1A1A01056956Korea University Guro Hospital (KOREA RESEARCH-DRIVEN HOSPITAL) grant No. O2400251National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) NRF-2022R1F1A1063966
6 · The paper itself

Abstract

Mild cognitive impairment (MCI) is a pre-dementia phase preceding dementia of the Alzheimer's type (DAT). Despite numerous studies exploring the risk factors for the conversion from MCI to DAT, the results have been heterogeneous. This study aimed to investigate the incidence of the conversion from MCI to DAT and the risk factors contributing to DAT conversion in Korean patients with MCI. A 12-year nationwide retrospective study was conducted. We enrolled patients with MCI aged ≥ 40 years between 2009 and 2015 and followed them up until 2020. The incidence of DAT conversion based on age at MCI diagnosis and its risk factors were analyzed using Cox proportional hazards regression. The conversion rate of DAT in patients with MCI increased during the age range of 70 to 90 years, and approached a plateau near the age of 100 years. Being underweight (hazard ratio [HR] 1.279, 95% confidence interval [CI] 1.223-1.338) was associated with a higher risk of DAT conversion. Cardiometabolic diseases (diabetes, HR 1.373, 95% CI 1.342-1.406; coronary heart disease, HR 1.047, 95% CI 1.015-1.079; and hemorrhagic stroke, HR 1.342, 95% CI 1.296-1.390;) increased the risk of DAT conversion, whereas hypertension, ischemic stroke, and dyslipidemia did not. Depression (HR 1.736, 95% CI 1.700-1.773) and physical inactivity (HR 1.193, 95% CI 1.161-1.227) were related to the increased risk. Mild (HR 0.860, 95% CI 0.830-0.891) to moderate (HR 0.880, 95% CI 0.837-0.926) alcohol consumption, high income (HR 0.947, 95% CI 0.925-0.970), and urban residence (HR 0.889, 95% CI 0.872-0.907) were associated with the decreased risk of DAT conversion. Multiple modifiable risk factors were closely associated with an increased risk of DAT conversion. Our results may help in designing preventive strategies to mitigate the risk of DAT conversion in patients with MCI.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAdultAgedAged, 80 and overDisease ProgressionFemaleHumansIncidenceMaleMiddle AgedProportional Hazards ModelsRepublic of KoreaRetrospective StudiesRisk FactorsDAT conversionDementia of the Alzheimer’s type (DAT)Mild cognitive impairmentRisk factors

Identifiers

PMID41073395
PMCPMC12514288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.